Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Wonkyung Jung, Baek-hui Kim

Clin Mol Hepatol. 2011;17(4):328-330. Published online December 26, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.4.328

View: 4908 Download: 42 Crossref: 4

Yoon Mi Jeen , So Young Jin

Clin Mol Hepatol. 2009;15(4):524-527. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.4.524

View: 4335 Download: 37 Crossref: 1

Haeryoung Kim, M.D., Ph.D., Young Nyun Park, M.D., Ph.D.

Clin Mol Hepatol. 2009;15(3):375-378. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.375

View: 3961 Download: 27

Hong Kyu Choi , Chan Ik Park , Jung Ah Shin , Jong Tae Moon , Se Joon Lee , Chan Il Park , Hyo Jin Park

Clin Mol Hepatol. 2008;12(2):126-129.

View: 1915 Download: 10

Jonathan Potack , Steven H. Itzkowitz

Clin Mol Hepatol. 2008;12(2):61-73.

View: 1909 Download: 17

1 |

Viewed By 5510	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4697	MAFLD: How is it different from NAFLD?
Viewed By 4428	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3626	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3595	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 78	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Search